Diagnosis and treatment of NMO spectrum disorder and MOG-encephalomyelitis
N Borisow, M Mori, S Kuwabara, M Scheel… - Frontiers in …, 2018 - frontiersin.org
Neuromyelitis optica spectrum disorders (NMOSD) are autoantibody mediated chronic
inflammatory diseases. Serum antibodies (Abs) against the aquaporin-4 water channel lead …
inflammatory diseases. Serum antibodies (Abs) against the aquaporin-4 water channel lead …
Transcranial magnetic stimulation as a potential biomarker in multiple sclerosis: a systematic review with recommendations for future research
Multiple sclerosis (MS) is a demyelinating disorder of the central nervous system. Disease
progression is variable and unpredictable, warranting the development of biomarkers of …
progression is variable and unpredictable, warranting the development of biomarkers of …
Assessments of vessel density and foveal avascular zone metrics in multiple sclerosis: an optical coherence tomography angiography study
Abstract Background/Objectives To investigate optical coherence tomography angiography
(OCT-A) findings of foveal avascular zone (FAZ) metrics and macular & peripapillary vessel …
(OCT-A) findings of foveal avascular zone (FAZ) metrics and macular & peripapillary vessel …
Suggestions for improving the design of clinical trials in multiple sclerosis—results of a systematic analysis of completed phase III trials
This manuscript reviews the primary and secondary endpoints of pivotal phase III trials with
immunomodulatory drugs in multiple sclerosis (MS). Considering the limitations of previous …
immunomodulatory drugs in multiple sclerosis (MS). Considering the limitations of previous …
Visualizing the central nervous system: imaging tools for multiple sclerosis and neuromyelitis optica spectrum disorders
J Kuchling, F Paul - Frontiers in Neurology, 2020 - frontiersin.org
Multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) are
autoimmune central nervous system conditions with increasing incidence and prevalence …
autoimmune central nervous system conditions with increasing incidence and prevalence …
Ozanimod for the treatment of relapsing remitting multiple sclerosis
L Rasche, F Paul - Expert Opinion on Pharmacotherapy, 2018 - Taylor & Francis
Introduction Ozanimod is a selective sphingosine 1-phosphate receptor 1 and 5 modulator
under development by Celgene, for the treatment of relapsing remitting multiple sclerosis …
under development by Celgene, for the treatment of relapsing remitting multiple sclerosis …
Optic chiasm measurements may be useful markers of anterior optic pathway degeneration in neuromyelitis optica spectrum disorders
Objectives We aimed to evaluate optic chiasm (OC) measures as potential imaging marker
for anterior optic pathway damage assessment in the context of neuromyelitis optica …
for anterior optic pathway damage assessment in the context of neuromyelitis optica …
The immediate effect of stroboscopic visual training on information-processing time in people with multiple sclerosis: an exploratory study
N Shalmoni, A Kalron - Journal of Neural Transmission, 2020 - Springer
Stroboscopic visual training (SVT) is a form of training aimed at improving visual and
perceptual performance by having individuals perform activities under conditions of …
perceptual performance by having individuals perform activities under conditions of …
Imaging correlates of visual function in multiple sclerosis
No single neuroimaging technique or sequence is capable of reflecting the functional
deficits manifest in MS. Given the interest in imaging biomarkers for short-to medium-term …
deficits manifest in MS. Given the interest in imaging biomarkers for short-to medium-term …
Fingolimod after a first unilateral episode of acute optic neuritis (MOVING)–preliminary results from a randomized, rater-blind, active-controlled, phase 2 trial
C Albert, J Mikolajczak, A Liekfeld, SK Piper, M Scheel… - BMC neurology, 2020 - Springer
Background Neuroprotection and promotion of remyelination represent important
therapeutic gaps in multiple sclerosis (MS). Acute optic neuritis (ON) is a frequent MS …
therapeutic gaps in multiple sclerosis (MS). Acute optic neuritis (ON) is a frequent MS …